Flores, Rosalie C.

HRN: 13-38-70  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2022
CO-AMOXICLAV 625MG (TAB)
05/16/2022
05/23/2022
PO
625
BID
UTI
Waiting Final Action 
05/24/2022
CEFUROXIME 500MG (TAB)
05/24/2022
05/30/2022
ORAL
500mg
BID
WBC 14, Pus Cells 8-10
Waiting Final Action 
05/25/2022
CEFUROXIME 750MG (VIAL)
05/25/2022
05/31/2022
IVT
1.5g
BID
UTI

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: